SAN JOSE, CALIFORNIA, 23 August, 2023- Complete Genomics, Inc., a pioneering genomic sequencing company, today proudly received the honor of the R&D 100 Awards from R&D World Magazine, often referred to as the “Oscars of Innovation”.
Vorolanib by Betta Pharmaceuticals for Thymic Carcinoma: Likelihood of Approval
Vorolanib is under clinical development by Betta Pharmaceuticals and currently in Phase II for Thymic Carcinoma.